Armistice Capital LinkedIn: Healthcare Investment Strategy Shows Focus on Rare Disease Innovation
OnThe landscape of biotech funding has demonstrated significant evolution, with particular momentum building in rare disease research despite broader market fluctuations. Industry data indicates.
Read More